OptimizeRx (OPRX) Accumulated Expenses (2010 - 2026)

OptimizeRx (OPRX) has 17 years of Accumulated Expenses data on file, last reported at $3.6 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 61.28% year-over-year to $3.6 million; the trailing twelve-month figure through Mar 2026 stood at $3.6 million (down 61.28% YoY), and the FY2025 full-year result was $11.6 million, up 36.59% from the prior year.
• Accumulated Expenses fell to $3.6 million in Q1 2026, from $11.6 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $12.5 million in Q2 2025 to a low of $750130.0 in Q4 2022.
• A 5-year average of $5.5 million and a median of $5.3 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses tumbled 74.16% in 2022 and jumped 927.29% in 2023, its largest moves.
• Tracing OPRX's Accumulated Expenses over 5 years: stood at $750130.0 in 2022, then jumped by 927.29% to $7.7 million in 2023, then climbed by 10.12% to $8.5 million in 2024, then jumped by 36.59% to $11.6 million in 2025, then sank by 69.01% to $3.6 million in 2026.
• Business Quant data shows OPRX's Accumulated Expenses at $3.6 million in Q1 2026, $11.6 million in Q4 2025, and $10.2 million in Q3 2025.